Authors:
Shakkottai, VG
Regaya, I
Wulff, H
Fajloun, Z
Tomita, H
Fathallah, M
Cahalan, MD
Gargus, JJ
Sabatier, JM
Chandy, KG
Citation: Vg. Shakkottai et al., Design and characterization of a highly selective peptide inhibitor of thesmall conductance calcium-activated K+ channel, SkCa2, J BIOL CHEM, 276(46), 2001, pp. 43145-43151
Authors:
Miller, MJ
Rauer, H
Tomita, H
Rauer, H
Gargus, JJ
Gutman, GA
Cahalan, MD
Chandy, KG
Citation: Mj. Miller et al., Nuclear localization and dominant-negative suppression by a mutant SKCa3N-terminal channel fragment identified in a patient with schizophrenia, J BIOL CHEM, 276(30), 2001, pp. 27753-27756
Authors:
Dror, V
Shamir, E
Ghanshani, S
Kimhi, R
Swartz, M
Barak, Y
Weizman, R
Avivi, L
Litmanovitch, T
Fantino, E
Kalman, K
Jones, EG
Chandy, KG
Gargus, JJ
Gutman, GA
Navon, R
Citation: V. Dror et al., hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats withschizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21, MOL PSYCHI, 4(3), 1999, pp. 254-260
Authors:
Antonarakis, SE
Blouin, JL
Lasseter, VK
Gehrig, C
Radhakrishna, U
Nestadt, G
Housman, DE
Kazazian, HH
Kalman, K
Gutman, G
Fantino, E
Chandy, KG
Gargus, JJ
Arm, E
Citation: Se. Antonarakis et al., Lack of linkage or association between schizophrenia and the polymorphic trinucleotide repeat within the KCNN3 gene on chromosome 1q21, AM J MED G, 88(4), 1999, pp. 348-351